240 related articles for article (PubMed ID: 27503933)
1. Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells.
Pang MF; Siedlik MJ; Han S; Stallings-Mann M; Radisky DC; Nelson CM
Cancer Res; 2016 Sep; 76(18):5277-87. PubMed ID: 27503933
[TBL] [Abstract][Full Text] [Related]
2. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
3. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
[TBL] [Abstract][Full Text] [Related]
4. The focal adhesion protein Integrin-Linked Kinase (ILK) as an important player in breast cancer pathogenesis.
Tsirtsaki K; Gkretsi V
Cell Adh Migr; 2020 Dec; 14(1):204-213. PubMed ID: 33043811
[TBL] [Abstract][Full Text] [Related]
5. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
6. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
7. ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance.
Tsoumas D; Nikou S; Giannopoulou E; Champeris Tsaniras S; Sirinian C; Maroulis I; Taraviras S; Zolota V; Kalofonos HP; Bravou V
Cancer Genomics Proteomics; 2018; 15(2):127-141. PubMed ID: 29496692
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
9. The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.
Kim H; Lin Q; Glazer PM; Yun Z
Breast Cancer Res; 2018 Mar; 20(1):16. PubMed ID: 29510720
[TBL] [Abstract][Full Text] [Related]
10. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
[TBL] [Abstract][Full Text] [Related]
11. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
12. Substratum stiffness signals through integrin-linked kinase and β1-integrin to regulate midbody proteins and abscission during EMT.
Rabie EM; Zhang SX; Dunn CE; Nelson CM
Mol Biol Cell; 2021 Aug; 32(18):1664-1676. PubMed ID: 34038147
[TBL] [Abstract][Full Text] [Related]
13. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
Acconcia F; Manavathi B; Mascarenhas J; Talukder AH; Mills G; Kumar R
Cancer Res; 2006 Nov; 66(22):11030-8. PubMed ID: 17108142
[TBL] [Abstract][Full Text] [Related]
14. The integrin-linked kinase gene up-regulated by hypoxia plays its pro-survival role in colorectal cancer cells.
Xiao L; Yue X; Ming X; Xu L; Ding M; Xu J; Liu Q
J Recept Signal Transduct Res; 2014 Feb; 34(1):64-72. PubMed ID: 24299190
[TBL] [Abstract][Full Text] [Related]
15. Substratum stiffness tunes proliferation downstream of Wnt3a in part by regulating integrin-linked kinase and frizzled-1.
Han S; Pang MF; Nelson CM
J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29588395
[TBL] [Abstract][Full Text] [Related]
16. Suppression of malignant growth of human breast cancer cells by ectopic expression of integrin-linked kinase.
Chen P; Shen WZ; Karnik P
Int J Cancer; 2004 Oct; 111(6):881-91. PubMed ID: 15300800
[TBL] [Abstract][Full Text] [Related]
17. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.
Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE
Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
19. Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue.
Lee SP; Youn SW; Cho HJ; Li L; Kim TY; Yook HS; Chung JW; Hur J; Yoon CH; Park KW; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(2):150-9. PubMed ID: 16818815
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
